my account  log out
 

Exemestane (Aromasin)

Create: 07/11/2019
Expired Date:12/31/2019
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:CAS: 89778-27-8 Molecular Formula: C20H24O2 Molecular Weight: 296.40 Molecular Structure: Exemestane Aromasin Anti Estrogen Steroids Pharmaceutical Raw Powder CAS 107868-30-4 Melting Point: 169 oC Boiling Point: 453.7 oC at 760 mmHg Density: 1.13 g/cm3 Refractive index: 1.572 1. Exemestane is a steroidal Aromatase Inhibitor (AI) that is most commonly known as Aromasin. In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. While tightly controlled by the pharmaceutical giant, Aromasin is available in numerous countries around the globe. 2. Aromasin was first released on the U.S. market in 2000 after shortly gaining FDA approval a few months prior in 1999. The primary purpose of use as with most AI's would be to combat breast cancer in post-menopausal women. Shortly after, the AI would begin to gain a lot of popularity among anabolic steroid users for its ability to protect against estrogenic related side effects. This action is very similar to the older and more popular AI's in Arimidex and Femara It would also gain a fair amount of popularity in Post Cycle Therapy (PCT) plans among steroid users. It was not the first AI to gain such popularity but would prove to be a little more advantageous for this purpose than most AI's. Web: www.rawsgear.com Web: www.rawsgearpharma.com Email: gear@quality-steroid.com Skype: +8615711952876 Whatsapp +8615711952876
City:Wuhan Hubei[CN] 
Location:
 
Jul 11 2019Clonidine hydrochloride309
Jul 11 2019Phenacetin299
Jul 11 2019CRL-40,940295
Jul 11 2019Pregabalin (4-Methylpregabalin)294
Jul 11 2019Phenylacetonitrile282
Jul 11 2019DMBA (1,3-Dimethylbutylamine hydrochloride)296
Jul 11 2019DMHA (1,5-dimethyl-hexylamin)299
Jul 11 2019DMAA (1,3-Dimethylamylamine)298
Jul 11 2019Setipiprant293
Jul 11 20191,3-dimethyl-butylamine citrate303

return back

Copyright © toextrade Inc. All rights reserved. Contact us